
Regencell Bioscience Holdings Limited
NASDAQ:RGC
14.5 (USD) • At close July 18, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operationele Activiteiten: | ||||||||||||||||||||
Nettowinst
| -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.002 | -0.001 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0 |
Afschrijvingen & Amortisatie
| 0 | 0 | 0 | 0 | 0.77 | 0 | 0 | 0 | 415.597 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.9 | 0 | 0 | 0 | -3.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Aandelen Gebaseerde Vergoedingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0.001 | -7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verandering in Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147.7 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 127.3 | 0 | 0 | 0 | 127.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.1 | 0 | 0 | 0 | -1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Crediteuren
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -39.9 | 0 | 0 | 0 | -39.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Overig Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.6 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
Overige Niet-Contante Posten
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0.001 | -0 | -0 | -0 | 0 | -0 | -0 |
Kasstroom uit Operationele Activiteiten
| 0 | 0 | 0 | 0 | 1.539 | 0 | 0 | 0 | -5,427.355 | 0 | 0 | 0 | -0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
Investeringsactiviteiten: | ||||||||||||||||||||
Investeringen in Materiële Vaste Activa
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -575.176 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
Netto Overnames
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9,634.3 | 0 | 0 | 0 | 160 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Kasstroom uit Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10,415.176 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 |
Financieringsactiviteiten: | ||||||||||||||||||||
Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -103.6 | 0 | 0 | 0 | -103.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Overige Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,483.716 | 0 | 0 | 0 | 103.6 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
Kasstroom uit Financieringsactiviteiten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22,380.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 |
Overige Informatie: | ||||||||||||||||||||
Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -408.413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Netto Kasstroomverandering
| 0 | 0 | 0 | 0 | 1.539 | 0 | 0 | 0 | 6,188.198 | 0 | 0 | 0 | -228.741 | 0 | -0 | -0 | -0 | -0 | 0 | 0 |
Kaspositie aan het Einde van de Periode
| 0 | 0 | 0 | 0 | 1.565 | 0 | 6.417 | 0 | 6,416.998 | 0 | 0 | 0 | 0.059 | 0 | -0 | 0 | 0 | 0.001 | 0.001 | 0 |